Originally developed to treat type 2 diabetes and later approved for conditions like obesity and sleep apnea, these medications are now being touted by influencers and researchers alike for their potential as longevity drugs. Notably, a growing cohort of health professionals has been examining the potential impact of GLP-1s on longevity markers, such as cholesterol and glucose levels, which can shed light on overall health
More frequent monitoring may be needed with oral semaglutide due to the known pharmacokinetic interaction that increases levothyroxine exposure by approximately 33%
Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence
Substancje, ktre nie zostay zatwierdzone jako leki lub wyroby medyczne, sprzedawane s na terenie Unii Europejskiej jako materia referencyjny
In a study on obese patients with COPD, authors examined the effect of the GLP-1 RA liraglutide (3.0 mg) for 40 weeks on pulmonary measures and the clinical impact of COPD
This is the adjustment period where your body adapts to the new signaling
